- NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure
- NeurAxis Reports First Quarter 2024 Financial Results
- NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
- NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
- NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024
- NeurAxis Announces New Medical Policy Coverage in North Dakota
- NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024
- NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
- NeurAxis Announces Highmark BCBS Policy Coverage
More ▼
Key statistics
On Friday, Neuraxis Inc (NRXS:ASQ) closed at 3.19, 77.22% above the 52 week low of 1.80 set on Oct 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.18 |
---|---|
High | 3.19 |
Low | 3.08 |
Bid | 1.12 |
Offer | -- |
Previous close | 3.12 |
Average volume | 6.08k |
---|---|
Shares outstanding | 6.65m |
Free float | 3.14m |
P/E (TTM) | -- |
Market cap | 21.21m USD |
EPS (TTM) | -3.71 USD |
Data delayed at least 15 minutes, as of Jul 26 2024 21:10 BST.
More ▼